Press Releases Kodiak Sciences Inc.

Equities

KOD

US50015M1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
3.11 ^USD	-4.60%		-16.84%	+2.30%

May. 15	Kodiak Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 14	Kodiak Sciences Inc. Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results	May. 15	PR
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	May. 15	AQ
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy	May. 13	PR
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform	May. 02	PR
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	Mar. 28	PR
Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024	Mar. 26	PR
Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting	Jan. 30	PR
Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 04	PR
Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference	Nov. 21	PR
Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights	Nov. 14	PR
Diabetic Retinopathy Pipeline, Clinical Trials, and Key Companies - Ocular Therapeutics , Novartis, Bayer	23-10-30	AQ
Kodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society	23-10-11	PR
Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference	23-09-11	AQ
Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference	23-09-08	PR
New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion	23-09-07	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD	23-08-18	PR
Kodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights	23-08-15	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD	23-08-10	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD	23-08-04	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD	23-07-26	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kodiak Sciences Inc.

Equities

KOD

US50015M1099

Press Releases

Filters